QuickLinks -- Click here to rapidly navigate through this document

As filed with the United States Securities and Exchange Commission on November 17, 2016

Registration No. 333-            

 

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549



FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933



BEIGENE, LTD.
(Exact Name of Registrant as Specified in Its Charter)



Cayman Islands
(State or Other Jurisdiction of
Incorporation or Organization)
  2834
(Primary Standard Industrial
Classification Code Number)
  98-1209416
(I.R.S. Employer
Identification Number)

c/o Mourant Ozannes Corporate Services (Cayman) Limited
94 Solaris Avenue, Camana Bay
Grand Cayman KY1-1108
Cayman Islands
+1 (345) 949 4123

(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Executive Offices)



C T Corporation System
111 Eighth Avenue
New York, New York 10011
(212) 894-8940

(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service)



Copies to:

Mitchell S. Bloom
Michael J. Kendall
Edwin M. O'Connor
Goodwin Procter LLP
100 Northern Avenue
Boston, MA 02210
(617) 570-1000

 

John V. Oyler
Chief Executive Officer and
Chairman
c/o Mourant Ozannes
Corporate
Services (Cayman) Limited
94 Solaris Avenue, Camana
Bay
Grand Cayman KY1-1108
Cayman Islands
+1 (345) 949 4123

 

Bruce K. Dallas
Davis Polk & Wardwell LLP
1600 El Camino Real
Menlo Park, California 94025
(650) 752-2000

Approximate date of commencement of proposed sale to the public:
As soon as practicable after the effective date of this registration statement.

          If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended, check the following box.     o

          If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.     ý

          If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.     o

          If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.     o

          Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer  o   Accelerated Filer  o   Non-Accelerated Filer  ý
(Do not check if a
smaller reporting company)
  Smaller Reporting Company  o

CALCULATION OF REGISTRATION FEE

       
 
Title of Each Class of Securities to be Registered (1)
  Proposed Maximum
Aggregate Offering
Price (2)(3)

  Amount of
Registration
Fee

Ordinary Shares, par value $0.0001 per share

  $28,750,000   $3,333

 


(1)
American depositary shares, or ADSs, evidenced by American depositary receipts issuable upon deposit of the ordinary shares registered hereby have been registered under a separate registration statement on Form F-6 (File No. 333-209044). Each ADS represents 13 ordinary shares.

(2)
Includes (i) ordinary shares represented by ADSs that may be purchased by the underwriters pursuant to their option to purchase additional ADSs and (ii) all ordinary shares represented by ADSs initially offered or sold outside the United States that are thereafter resold from time to time in the United States.

(3)
Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended.

           This registration statement shall become effective upon filing with the Commission in accordance with Rule 462(b) of the Securities Act of 1933, as amended.

   



EXPLANATORY NOTE AND INCORPORATION BY REFERENCE

This Registration Statement is being filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended (the "Securities Act"). The contents of the Registration Statement on Form S-1 (File No. 333-214540) filed by BeiGene, Ltd. with the Securities and Exchange Commission (the "Commission") pursuant to the Securities Act, which was declared effective by the Commission on November 17, 2016, including the exhibits thereto, are incorporated by reference into this Registration Statement.

The required opinion and consents are listed on an Exhibit Index attached hereto and filed herewith.

2



SIGNATURES

        Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Hong Kong, on November 17, 2016.

    BEIGENE, LTD.

 

 

By:

 

/s/ JOHN V. OYLER

        Name:   John V. Oyler
        Title:   Chief Executive Officer and Chairman

Signature
 
Title
 
Date

 

 

 

 

 

 

 

 

 
/s/ JOHN V. OYLER

John V. Oyler
  Chief Executive Officer, Chairman and Director (Principal Executive Officer)   November 17, 2016

/s/ HOWARD LIANG

Howard Liang

 

Chief Financial Officer and Chief Strategy Officer (Principal Financial and Accounting Officer)

 

November 17, 2016

*

Timothy Chen

 

Director

 

November 17, 2016

*

Donald W. Glazer

 

Director

 

November 17, 2016

*

Michael Goller

 

Director

 

November 17, 2016

*

Ranjeev Krishana

 

Director

 

November 17, 2016

*

Thomas Malley

 

Director

 

November 17, 2016

*

Ke Tang

 

Director

 

November 17, 2016

II-1


Signature
 
Title
 
Date

 

 

 

 

 

 

 

 

 

*

Xiaodong Wang

 

Director

 

November 17, 2016

*

Qingqing Yi

 

Director

 

November 17, 2016

BeiGene USA, Inc.

 

 

 

 

By:

 

/s/ JOHN V. OYLER


 

Authorized Representative in the

 

November 17, 2016
    Name:   John V. Oyler   United States    
    Title:   Chief Executive Officer        

 


*By:

 

/s/ JOHN V. OYLER


 

Attorney-in-Fact

 

November 17, 2016
    John V. Oyler        

II-2



Exhibit Index

Exhibit No.   Exhibit Title
  5.1   Opinion of Mourant Ozannes
  23.1   Consent of Ernst & Young Hua Ming LLP
  23.2   Consent of Mourant Ozannes (included in Exhibit 5.1)
  24.1   Power of Attorney (incorporated by reference to Registration Statement on Form S-1 (File No. 333-214540) filed November 10, 2016)

II-3




QuickLinks

EXPLANATORY NOTE AND INCORPORATION BY REFERENCE
SIGNATURES
Exhibit Index

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 5.1

    6th Floor
125 Old Broad Street
London EC2N 1AR
T +44 20 7796 7600
F +44 20 7786 7699
mourantozannes.com

BeiGene, Ltd.
94 Solaris Avenue
Camana Bay
PO Box 1348
Grand Cayman, KY1-1108
Cayman Islands

17 November 2016

Dear Sirs and Mesdames,

BeiGene, Ltd. ( the Company )

We have acted as Cayman Islands legal advisers to the Company in connection with the Company's registration statement on Form S-1 (File No. 333-214540), including all amendments or supplements thereto (the Registration Statement ), filed with the Securities and Exchange Commission under the U.S. Securities Act of 1933, as amended to date and the related registration statement filed pursuant to Rule 462(b) of the U.S. Securities Act of 1933, as amended, (the Rule 462(b) Registration Statement ), relating to the offering (the Offering ) by the Company and certain shareholders of the Company (the Selling Shareholders ) of certain American Depositary Shares (the ADSs ) representing the Company's ordinary shares of par value US$0.0001 each (the Shares ).

We are furnishing this opinion as Exhibit 5.1 to the Rule 462(b) Registration Statement.

1.     Documents Reviewed

For the purposes of this opinion we have examined a copy of each of the following documents:

(a)
The certificate of incorporation of the Company dated 28 October 2010.

(b)
The Fourth Amended and Restated Memorandum and Articles of Association of the Company as adopted by a special resolution passed on 14 January 2016 and effective on 8 February 2016 (the M&A ).

(c)
The minutes of the meetings of the directors of the Company held on 14 January 2016 and 27 September 2016 (the Directors' Resolutions ).

(d)
The minutes of the extraordinary general meeting of the shareholders of the Company held on 14 January 2016 (the Shareholders' Resolutions and together with the Directors' Resolutions the Resolutions ).

(e)
A certificate from a Director of the Company addressed to this firm a copy of which is attached hereto (the Director's Certificate ).

(f)
A certificate of good standing dated 16 November 2016, issued by the Registrar of Companies in the Cayman Islands (the Certificate of Good Standing ).

(g)
The Registration Statement and the Rule 462(b) Registration Statement.

   

Mourant Ozannes is a Cayman Islands partnership
A list of the partners is available at mourantozannes.com


2.     Assumptions

The following opinions are given only as to, and based on, circumstances and matters of fact existing and known to us on the date of this opinion letter. These opinions only relate to the laws of the Cayman Islands which are in force on the date of this opinion letter. In giving these opinions we have relied (without further verification) upon the completeness and accuracy of the Director's Certificate and the Certificate of Good Standing. We have also relied upon the following assumptions, which we have not independently verified:

2.1
Copy documents or drafts of documents provided to us are true and complete copies of, or in the final forms of, the originals.

2.2
The genuineness of all signatures and seals.

2.3
There is nothing under any law (other than the law of the Cayman Islands) which would or might affect the opinions set out below.

3.     Opinion

Based upon the foregoing and subject to the qualifications set out below and having regard to such legal considerations as we deem relevant, we are of the opinion that:

3.1
The Company has been duly incorporated as an exempted company with limited liability and is validly existing and in good standing under the laws of the Cayman Islands.

3.2
The authorised share capital of the Company is US$1,000,000 divided into 9,500,000,000 Ordinary Shares of a par value of US$0.0001 each and 500,000,000 shares of a par value of US$0.0001 each of such class or classes (however designated) as the board of directors may determine in accordance with the M&A.

3.3
The issue and allotment of the Shares to be sold by the Company have been duly authorised and when allotted, issued and paid for as contemplated in the Rule 462(b) Registration Statement, the Shares will be legally issued and allotted, fully paid and non-assessable. As a matter of Cayman Islands law, a share is only issued when it has been entered in the register of members (shareholders).

3.4
The Shares to be sold by the Selling Shareholders have been duly authorised and are legally issued and allotted, fully paid and non-assessable.

3.5
The statements under the caption Taxation in the prospectus forming part of the Rule 462(b) Registration Statement, to the extent that they constitute statements of Cayman Islands law, are accurate in all material respects and that such statements constitute our opinion.

4.     Qualifications

Except as specifically stated herein, we make no comment with respect to any representations and warranties which may be made by or with respect to the Company in any of the documents or instruments cited in this opinion or otherwise with respect to the commercial terms of the transactions the subject of this opinion.

In this opinion the phrase non-assessable means, with respect to Shares in the Company, that a member shall not, solely by virtue of its status as a member, be liable for additional assessments or calls on the Shares by the Company or its creditors (except in exceptional circumstances and subject to the M&A, such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil).

We hereby consent to the filing of this opinion as an exhibit to the Rule 462(b) Registration Statement and to the reference to our name under the headings Enforceability of Civil Liabilities , Taxation and Legal Matters and elsewhere in the Registration Statement. In giving such consent, we do not hereby admit that we come within the category of persons whose consent is required under Section 7 of the U.S. Securities Act of 1933, as amended, or the Rules and Regulations of the Commission thereunder.

Yours faithfully

/s/ Mourant Ozannes

Mourant Ozannes

Enc.




QuickLinks


QuickLinks -- Click here to rapidly navigate through this document


Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

        We consent to the incorporation by reference in the Registration Statement on Form S-1 filed pursuant to Rule 462(b) of the Securities Act of 1933, as amended, of the reference to our firm under the caption "Experts" and to the incorporation by reference of our report dated March 29, 2016, with respect to the consolidated financial statements of BeiGene, Ltd. incorporated by reference in Amendment No. 1 to the Registration Statement (Form S-1 No. 333-214540) and related Prospectus of BeiGene, Ltd. for the registration of its ordinary shares in the form of American Depositary Shares.

/s/ Ernst & Young Hua Ming LLP
Beijing, People's Republic of China
November 17, 2016




QuickLinks